{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T15:13:49Z","timestamp":1716650029492},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC81170003","81370109"],"award-info":[{"award-number":["NSFC81170003","81370109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Commission","award":["134119a6400, 12JC1402300 and XYQ 2011006"],"award-info":[{"award-number":["134119a6400, 12JC1402300 and XYQ 2011006"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pupt.2014.03.005","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T16:22:43Z","timestamp":1396369363000},"page":"250-254","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pathogen characteristics reveal novel antibacterial approaches for interstitial lung disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Hai-Wen","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Bin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Chao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-Wu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2014.03.005_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2014.03.005_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar3097","article-title":"Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management","volume":"12","author":"Castelino","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pupt.2014.03.005_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2169\/internalmedicine.47.0402","article-title":"Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia","volume":"47","author":"Enomoto","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.pupt.2014.03.005_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccm.2012.01.004","article-title":"Interstitial lung disease in the connective tissue diseases","volume":"33","author":"Antin-Ozerkis","year":"2012","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.pupt.2014.03.005_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.12-0741","article-title":"Diagnosis and treatment of connective tissue disease-associated interstitial lung disease","volume":"143","author":"Vij","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2014.03.005_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5578\/tt.3486","article-title":"Interstitial lung disease associated with connective tissue diseases: diagnosis and treatment approaches","volume":"60","author":"Kar Kurt","year":"2012","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.pupt.2014.03.005_bib7","doi-asserted-by":"crossref","unstructured":"Ogna A, Noirez L, Lazor R, Nicod LP. Respiratory bronchiolitis and respiratory bronchiolitis-associated interstitial lung disease. Rev Med Suisse 8:2228\u201332.","DOI":"10.53738\/REVMED.2012.8.363.2228"},{"key":"10.1016\/j.pupt.2014.03.005_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.iac.2012.09.002","article-title":"Connective tissue disease-associated lung disease","volume":"32","author":"Olson","year":"2012","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.pupt.2014.03.005_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2009.04322.x","article-title":"Prevention and treatment of systemic glucocorticoid side effects","volume":"49","author":"Moghadam-Kia","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pupt.2014.03.005_bib10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.rmed.2010.02.008","article-title":"Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis","volume":"104","author":"Nathan","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2014.03.005_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.iac.2012.07.001","article-title":"Immunosuppressive therapy for autoimmune lung diseases","volume":"32","author":"Meyer","year":"2012","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.pupt.2014.03.005_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/SMJ.0b013e3180485c62","article-title":"A\u00a0clinician's guide to the diagnosis and treatment of interstitial lung diseases","volume":"100","author":"Danoff","year":"2007","journal-title":"South Med J"},{"key":"10.1016\/j.pupt.2014.03.005_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MCP.0b013e3283483e76","article-title":"Newer modes of treating interstitial lung disease","volume":"17","author":"Wuyts","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.pupt.2014.03.005_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1753465808096948","article-title":"Therapies for interstitial lung disease: past, present and future","volume":"2","author":"Kim","year":"2008","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.pupt.2014.03.005_bib15","first-page":"325","article-title":"The survey of bacterial drug resistance in 2007 China CHINET","volume":"8","author":"Wang","year":"2008","journal-title":"Chin J Inf Chem"},{"key":"10.1016\/j.pupt.2014.03.005_bib16","first-page":"1","article-title":"Interstitial lung disease and infections","volume":"29","author":"Li","year":"2008","journal-title":"J\u00a0Tongji Univ (Medical Science)"},{"key":"10.1016\/j.pupt.2014.03.005_bib17","article-title":"Idiopathic pulmonary fibrosis is strongly associated with productive infection by Herpesvirus saimiri","author":"Folcik","year":"2013","journal-title":"Mod Pathol"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553914000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553914000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T14:56:22Z","timestamp":1716648982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553914000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1094553914000376"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2014.03.005","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogen characteristics reveal novel antibacterial approaches for interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2014.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}